Isthmus Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.4M Sell
80,497
-1,136
-1% -$265K 1.98% 7
2026
Q1
$20M Sell
81,633
-16,324
-17% -$3.8M 2.09% 4
2025
Q4
$20.3M Sell
97,957
-1,326
-1% -$262K 2.25% 5
2025
Q3
$18.4M Sell
99,283
-341
-0.3% -$58.4K 4.08% 2
2025
Q2
$15.2M Buy
99,624
+17
+0% +$2.61K 1.78% 12
2025
Q1
$16.5M Sell
99,607
-168
-0.2% -$26.3K 2.07% 6
2024
Q4
$14.4M Buy
99,775
+2,280
+2% +$353K 1.75% 17
2024
Q3
$15.8M Buy
97,495
+1,765
+2% +$281K 1.88% 11
2024
Q2
$14M Sell
95,730
-220
-0.2% -$32.7K 1.65% 14
2024
Q1
$15.2M Buy
95,950
+22,194
+30% +$3.53M 1.72% 11
2023
Q4
$11.6M Buy
73,756
+4,401
+6% +$675K 1.5% 26
2023
Q3
$10.8M Buy
69,355
+1,135
+2% +$187K 1.56% 18
2023
Q2
$11.3M Buy
68,220
+1,091
+2% +$176K 1.54% 19
2023
Q1
$10.4M Buy
67,129
+1,898
+3% +$306K 1.47% 24
2022
Q4
$11.5M Sell
65,231
-815
-1% -$141K 1.73% 7
2022
Q3
$10.8M Buy
66,046
+198
+0.3% +$33.5K 1.86% 6
2022
Q2
$11.7M Buy
65,848
+668
+1% +$119K 2.18% 5
2022
Q1
$11.6M Buy
65,180
+2,293
+4% +$390K 1.9% 10
2021
Q4
$10.8M Buy
62,887
+984
+2% +$161K 1.8% 16
2021
Q3
$10M Buy
61,903
+510
+0.8% +$87K 1.81% 18
2021
Q2
$10.1M Sell
61,393
-1,083
-2% -$179K 1.78% 14
2021
Q1
$10.3M Sell
62,476
-884
-1% -$143K 1.88% 14
2020
Q4
$9.97M Buy
63,360
+248
+0.4% +$36.6K 2.02% 9
2020
Q3
$9.4M Buy
63,112
+100
+0.2% +$14.8K 2.19% 10
2020
Q2
$8.86M Sell
63,012
-104
-0.2% -$15.2K 2.18% 6
2020
Q1
$8.28M Sell
63,116
-423
-0.7% -$60K 2.54% 4
2019
Q4
$9.27M Sell
63,539
-541
-0.8% -$73.4K 2.11% 7
2019
Q3
$8.29M Buy
64,080
+575
+0.9% +$75.8K 1.96% 14
2019
Q2
$8.85M Buy
+63,505
New +$8.79M 2.11% 7
2019
Q1
Sell
-60,302
Closed -$7.78M 162
2018
Q4
$7.78M Buy
60,302
+1,571
+3% +$219K 2.34% 7
2018
Q3
$8.12M Buy
58,731
+448
+0.8% +$59.5K 2.05% 14
2018
Q2
$7.07M Buy
58,283
+459
+0.8% +$57.3K 1.84% 20
2018
Q1
$7.41M Buy
57,824
+230
+0.4% +$31.1K 2% 14
2017
Q4
$8.05M Sell
57,594
-642
-1% -$89.4K 2.19% 3
2017
Q3
$7.57M Sell
58,236
-718
-1% -$95.2K 2.13% 7
2017
Q2
$7.8M Sell
58,954
-1,761
-3% -$225K 2.28% 3
2017
Q1
$7.56M Sell
60,715
-18
-0% -$2.15K 2.22% 5
2016
Q4
$7M Buy
60,733
+773
+1% +$89.3K 2.11% 8
2016
Q3
$7.07M Sell
59,960
-1,870
-3% -$227K 2.24% 5
2016
Q2
$7.5M Sell
61,830
-1,405
-2% -$160K 2.47% 1
2016
Q1
$6.84M Sell
63,235
-624
-1% -$64.6K 2.28% 4
2015
Q4
$6.56M Sell
63,859
-863
-1% -$86.8K 2.29% 9
2015
Q3
$6.04M Sell
64,722
-28
-0% -$2.71K 2.22% 7
2015
Q2
$6.31M Buy
64,750
+491
+0.8% +$49.2K 2.09% 9
2015
Q1
$6.46M Buy
64,259
+1,596
+3% +$162K 2.19% 9
2014
Q4
$6.55M Buy
+62,663
New +$6.6M 2.23% 9

Other funds holding JNJ

Isthmus Partners's JNJ Position: Q2 2026 in Review

Isthmus Partners reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $265K and leaving 80,497 shares worth $20.4M. The position accounts for 1.98% of the portfolio, ranked #7.

Isthmus Partners first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Isthmus Partners held 80,497 shares of Johnson & Johnson worth $20.4M as of Q2 2026.
  • Isthmus Partners sold 1,136 Johnson & Johnson shares in Q2 2026, an estimated $265K.
  • Johnson & Johnson made up 1.98% of Isthmus Partners's portfolio in Q2 2026, its #7 holding.
  • Isthmus Partners first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.